Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Steve Balk"'
Autor:
Rosina T. Lis, Jett Crowdis, Alok K. Tewari, Myles Brown, Dimitri Livitz, Alexander T. M. Cheung, Sabrina Y. Camp, Meng Xiao He, Ignaty Leshchiner, Jake Conway, Zhenwei Zhang, Saud H. AlDubayan, Mary-Ellen Taplin, Steve Balk, Gad Getz, Alice Boosma-Moody, Eliezer M. Van Allen, Rana R. McKay, Jihye Park, Stephanie A. Wankowicz
Publikováno v:
Cell Reports. 36:109665
High-risk localized prostate cancer (HRLPC) is associated with a substantial risk of recurrence and prostate cancer-specific mortality1. Recent clinical trials have shown that intensifying anti-androgen therapies administered prior to prostatectomy c
Autor:
Mary Ellen Morrissey, Glenn J. Bubley, Meredith M. Regan, Christos S. Mantzoros, William C. DeWolf, Steve Balk, Ellena Salgami, Stephen Duggan
Publikováno v:
Journal of Urology. 168:2249-2252
Purpose: Elevated serum levels of insulin-like growth factor-1 (IGF-1) have been consistently shown to be a risk factor for prostate cancer. Alterations in serum IGF-1 binding proteins 1 to 3 have also been associated with prostate cancer risk. A pot
Autor:
Glenn J. Bubley, Robin Joyce, Mary-Ellen Taplin, Geert J. C. M. Kolvenbag, Mary Anne Fenton, Steve Balk, Michael Constantine, William C. DeWolf, Paola Rode, Lisa Gaynes
Publikováno v:
Journal of Urology. 159:149-153
A pilot study of the antiandrogen bicalutamide at 150 mg. a day for androgen independent prostate cancer was performed. This study was based on the possibility that androgen independent cases might display responses to additional hormonal agents.The
Autor:
Glenn J. Bubley, Steve Balk, Vikas P. Sukhatme, Othon Iliopoulos, Joelle Torregrossa, Shaoyong Chen, Rupal S. Bhatt, Daniel M. Landis, Michael Zimmer
OBJECTIVE To determine the role of hypoxia-inducible factor-2alpha (HIF2alpha) on the sensitivity of renal cell carcinoma (RCC) cell lines to ionizing radiation and to determine if the mTOR antagonist, rapamycin, could decrease HIF2alpha protein leve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98aed9203e002ecf1f57b123345f6b72
https://europepmc.org/articles/PMC4112353/
https://europepmc.org/articles/PMC4112353/
Publikováno v:
Cancer Research. 75:966-966
Androgen receptor (AR) plays a pivotal role in prostate cancer (PCa) and remains critical for more aggressive castration-resistant PCa (CRPC) through transactivation of multiple genes. Although CRPC is generally responsive to further CYP17A1 inhibiti
Autor:
Dimitrios, Spentzos, Christos, Mantzoros, Meredith M, Regan, Mary Ellen, Morrissey, Stephen, Duggan, Stacy, Flickner-Garvey, Heather, McCormick, William, DeWolf, Steve, Balk, Glenn J, Bubley
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(9)
The effects of a low-fat diet or a low-fat diet with the addition of a soy supplement were investigated in a pilot Phase II study for asymptomatic, hormonally naive prostate cancer patients with rising prostate-specific antigen (PSA) levels.A two-ste
Publikováno v:
ASAIO Journal. 52:33A